Back
Onco3R Taps Founder of $1.75B Biotech Exit as Chairman
Back
Stock News
Themes
Onco3R Taps Founder of $1.75B Biotech Exit as Chairman
CAR-T Therapy
Onco3R Taps Founder of $1.75B Biotech Exit as Chairman
Edgen Stock
·
Jan 08 2026, 10:02
Share to
Share to
Copy link
source:
[1] Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics
Recommend
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17
US-China AI Rivalry Enters New Phase Focused on Compute Power and Cybersecurity
Nov 28 2025, 10:17
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17